ScholarIQanswers from OpenAlex

Fremanezumab for the Preventive Treatment of Chronic Migraine

PaperCitations, authors & open-access status

Fremanezumab for the Preventive Treatment of Chronic Migraine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fremanezumab for the Preventive Treatment of Chronic Migraine have?

ScholarIQcitation count

Fremanezumab for the Preventive Treatment of Chronic Migraine has 811 citations in the OpenAlex counts ScholarIQ stores.

When was Fremanezumab for the Preventive Treatment of Chronic Migraine published?

ScholarIQyear

Fremanezumab for the Preventive Treatment of Chronic Migraine has 2017 year in the ScholarIQ index.

What is the open-access status of Fremanezumab for the Preventive Treatment of Chronic Migraine?

ScholarIQoa status

Fremanezumab for the Preventive Treatment of Chronic Migraine has green oa status in the ScholarIQ index.

What is the DOI of Fremanezumab for the Preventive Treatment of Chronic Migraine?

ScholarIQdoi

The DOI for Fremanezumab for the Preventive Treatment of Chronic Migraine is on the source record.

What is the PMID of Fremanezumab for the Preventive Treatment of Chronic Migraine?

ScholarIQpmid

The PMID for Fremanezumab for the Preventive Treatment of Chronic Migraine is on the source record.

What is the OpenAlex record for Fremanezumab for the Preventive Treatment of Chronic Migraine?

ScholarIQopenalex

The OpenAlex for Fremanezumab for the Preventive Treatment of Chronic Migraine is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial